MSN FPX 6021 Change Strategy and Implementation KP Change Strategy and Implementation  MSN FPX 6021 Change Strategy and Implementation KP

MSN FPX 6021 Change Strategy and Implementation KP

Change Strategy and Implementation 

MSN FPX 6021 Change Strategy and Implementation KP

The Centers for Disease Control and Prevention (CDC) was granted by Congress in 2010 to create and start the National Diabetes Prevention Program (National DPP). National DPP is a  public and private program that offers evidence-based, cost-effective involvements in societies across the United States to avoid type 2 diabetes. This program creates partnerships between  community-based administrations, private insurers, health care professionals, companies,  healthcare institutions and management agencies and is inspiring these entities to work  collaboratively to decrease the occurrence of prediabetes and type 2 diabetes (Butler & Kirk,  2020). A key factor of the Nationwide DPP is evidence-based diabetes prevention programs  (DPPs)– which educates the individuals to make long-lasting lifestyle changes, like eating better,  adding physical activity into their daily practices, and bettering their coping skills to avoid or  delay the beginning of type 2 diabetes. To safeguard high quality, CDC only identifies DPPs that  meet precise and detailed standards- and are proven to accomplish the goals. These standards  include carrying out the reviewed curriculum created by the CDC and DPP’s, facilitation by a  healthcare professional and its team, and submitting the statistics annually to show that the program is having an impact.  

Diabetes self-management education and support (DSMES) services enables patients to  access knowledge, learn skills, and provide decision making to optimize diabetes self-care and  integrate the needs, life experiences, and goals of the individual with diabetes. The general purposes of DSMES are to support informed decision-making, problem-solving, self-care  behavior, and dynamic collaboration with the healthcare professional team to better the  individuals’ clinical results, better health status, and welfare in a cost-effective manner (Butler &  Kirk, 2020). 

3 

Diabetes and Hyperlipidemia 

Individuals with type 2 diabetes, coronary artery disease is the most common cause of  death (Reamy, 2018). It has been commonly seen that lipid abnormalities are linked with  diabetes, particularly in those with type diabetes mellitus type 2. The most common lipid  irregularities in these individuals include hyper-triglyceridemic and a low high-density  lipoprotein (HDL) cholesterol level. While lipid abnormalities characteristically get better with  better glycemic control and a decreased A1C level, regularization does not usually happen. This  is due to there a strong connection between all forms of vascular illness in patients with diabetes  type 2 and hyperlipidemia, it is imperative to have the individual get frequent blood tests and  treat the elevated lipid levels.